ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,494Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 99

$618K Total Retail Price of All Prescriptions

Rank: 4 out of 99

488 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 488 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 488 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 9,181 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 684 580 1 3
LEVOTHYROXINE SODIUM 444 414 2 6
HYDROCODONE-ACETAMINOPHEN 303 266 S3 3 1
OMEPRAZOLE 288 241 4 2
AMLODIPINE BESYLATE 280 268 5 4
METFORMIN HCL 253 184 6 26
LISINOPRIL 253 216 6 5
ATORVASTATIN CALCIUM 239 216 8 23
WARFARIN SODIUM 235 212 9 17
LOSARTAN POTASSIUM 227 220 10 19
POTASSIUM CHLORIDE 210 201 11 18
LOSARTAN-HYDROCHLOROTHIAZIDE 198 179 12 52
HYDROCHLOROTHIAZIDE 185 170 13 22
FUROSEMIDE 168 160 14 7
CARVEDILOL 156 153 15 21
DONEPEZIL HCL 147 147 16 71
SERTRALINE HCL 147 141 16 60
ATENOLOL 146 146 18 25
TRAMADOL HCL 141 113 19 30
ZOLPIDEM TARTRATE 118 116 20 63
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 110 21 58
METOPROLOL TARTRATE 108 104 22 20
GABAPENTIN 106 83 23 9
METOPROLOL SUCCINATE 106 85 23 13
FLUTICASONE PROPIONATE 104 94 25 27
TRIAMTERENE-HCTZ 101 94 26 109
ALLOPURINOL 100 88 27 16
EVISTA 98 98 28 162
CITALOPRAM HBR 83 68 29 36
TAMSULOSIN HCL 82 82 30 11
ZETIA 79 62 31 83
DIOVAN 77 77 32 75
DETROL LA 77 65 32 175
ALENDRONATE SODIUM 67 67 34 28
LANTUS 64 60 35 38
CRESTOR 63 63 36 33
GLIMEPIRIDE 62 62 37 189
NAMENDA 62 62 37 42
FLUOXETINE HCL 61 59 39 191
SPIRIVA 60 60 40 114
TRAZODONE HCL 58 57 41 119
FAMOTIDINE 58 32 41 67
TERAZOSIN HCL 58 58 41 44
VYTORIN 57 44 44 82
CIPROFLOXACIN HCL 55 54 45 40
AZITHROMYCIN 54 45 46 152
GLYBURIDE 53 28 R 47 107
AMITRIPTYLINE HCL 51 49 R 48 108
MELOXICAM 51 51 48 24
KLOR-CON M10 51 51 48 211
NIASPAN 51 50 48 106
PROAIR HFA 50 34 52 215
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.